Literature DB >> 27842227

Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach.

Marco Tutone1, Ugo Perricone2, Anna Maria Almerico2.   

Abstract

In a previous work, we developed the in house Virtual Lock-and-Key Approach (VLKA) in order to evaluate target assignment starting from molecular descriptors calculated on known inhibitors used as an information source. This protocol was able to predict the correct biological target for the whole dataset with a good degree of reliability (80%), and proved experimentally, which was useful for the target fishing of unknown compounds. In this paper, we tried to remodel the previous in house developed VLKA in a more sophisticated one in order to evaluate the influence of 3D conformation of ligands on the accuracy of the prediction. We applied the same previous algorithm of scoring and ranking but, this time, combining it with a structure-based approach as docking. For this reason, we retrieved from the RCSB Protein Data Bank (PDB), the available 3D structures of the biological targets included into the previous work, and we used them to calculate poses of the 7352 dataset compounds in the VLKA biological targets. First, docking protocol has been used to retrieve docking scores, then, from the docked poses of each molecule, 3D-descriptors were calculated (Conf-VLKA), While the use of the simple docking scores proved to be inadequate to improve compounds classification, the Conf-VLKA showed some interesting variations compared to the original VLKA, especially for targets whose ligands present a high number of rotamers. This work represent a first preliminary study to be completed using other techniques such as induced fit docking or molecular dynamics structure clustering to take into account the protein side chains adaptation to ligands structures.
Copyright © 2016 Elsevier Inc. All rights reserved.

Keywords:  Biological target; Descriptors; Docking; Inhibitors; Ligand-based; Structure-based; Target fishing; Vlka

Mesh:

Substances:

Year:  2016        PMID: 27842227     DOI: 10.1016/j.jmgm.2016.11.006

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  4 in total

1.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

2.  Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor.

Authors:  Hani A Alhadrami; Ahmed M Sayed; Heba Al-Khatabi; Nabil A Alhakamy; Mostafa E Rateb
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-05

3.  In Silico-Based Discovery of Natural Anthraquinones with Potential against Multidrug-Resistant E. coli.

Authors:  Hani A Alhadrami; Wesam H Abdulaal; Hossam M Hassan; Nabil A Alhakamy; Ahmed M Sayed
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-11

4.  Neoechinulin A as a Promising SARS-CoV-2 Mpro Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors.

Authors:  Hani A Alhadrami; Gaia Burgio; Bathini Thissera; Raha Orfali; Suzan E Jiffri; Mohammed Yaseen; Ahmed M Sayed; Mostafa E Rateb
Journal:  Mar Drugs       Date:  2022-02-24       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.